These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities. Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517 [TBL] [Abstract][Full Text] [Related]
4. Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease. Lee ES; Kim N; Lee SH; Park YS; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS Aliment Pharmacol Ther; 2009 Jul; 30(2):154-64. PubMed ID: 19392871 [TBL] [Abstract][Full Text] [Related]
5. More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy. Kusano M; Hosaka H; Kawamura O; Kawada A; Kuribayashi S; Shimoyama Y; Yasuoka H; Mizuide M; Tomizawa T; Sagawa T; Sato K; Yamada M J Gastroenterol; 2015 Mar; 50(3):298-304. PubMed ID: 24919745 [TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of recurrence rate and symptom improvement in gastro-esophageal reflux disease patients]. Jeong YJ; Lee DH; Choi TH; Hwang TJ; Lee BH; Nah JC; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Kim N; Jung HC; Song IS Korean J Gastroenterol; 2010 Feb; 55(2):100-8. PubMed ID: 20168056 [TBL] [Abstract][Full Text] [Related]
7. Non-erosive reflux disease (NERD), symptomatic and asymptomatic erosive reflux disease (ERD): from hypersensitive to hyposensitive esophagus. Hartono JL; Qua CS; Goh KL Dig Dis Sci; 2011 Jan; 56(1):90-6. PubMed ID: 20467897 [TBL] [Abstract][Full Text] [Related]
8. Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group. Lee KJ; Kwon HC; Cheong JY; Cho SW Digestion; 2009; 79(3):131-6. PubMed ID: 19307735 [TBL] [Abstract][Full Text] [Related]
9. The Prevalence and Clinical Features of Non-responsive Gastroesophageal Reflux Disease to Practical Proton Pump Inhibitor Dose in Korea: A Multicenter Study. Park HJ; Park SH; Shim KN; Kim YS; Kim HJ; Han JP; Kim YS; Bang BW; Kim GH; Baik GH; Kim HH; Park SY; Kim SS Korean J Gastroenterol; 2016 Jul; 68(1):16-22. PubMed ID: 27443619 [TBL] [Abstract][Full Text] [Related]
10. The effects of proton pump inhibitors on autonomic tone in patients with erosive and non-erosive esophagitis. Jones EL; Perring S; Khattab A; Allenby-Smith O Neurogastroenterol Motil; 2016 May; 28(5):659-64. PubMed ID: 26748487 [TBL] [Abstract][Full Text] [Related]
11. [Acid-suppressive strategy against gastroesophageal reflux diseases and non-erosive reflux diseases: the alternative of proton- pump inhibitors or H2 receptor antagonists]. Ishino Y; Sugano K Nihon Rinsho; 2007 May; 65(5):891-4. PubMed ID: 17511229 [TBL] [Abstract][Full Text] [Related]
12. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus. Hak NG; Mostafa M; Salah T; El-Hemaly M; Haleem M; Abd El-Raouf A; Hamdy E Hepatogastroenterology; 2008; 55(82-83):442-7. PubMed ID: 18613384 [TBL] [Abstract][Full Text] [Related]